Takeaways Blenrep’s pCPA negotiations are an important step toward broader Canadian access to a new multiple myeloma option, especially because the drug is being positio...
Home / Relapsed or Refractory Multiple Myeloma
Browsing Tag: Relapsed or Refractory Multiple Myeloma
Social Icons
Featured Posts
AbbVie’s Boey Approved in Canada for Glabellar Lines
June 24, 2026Roche’s Itovebi Moves Closer to Public Access in Canada
June 24, 2026

